There is a Sure Cure, But It's Not Covered by Your Health Insurance Plan

  • Newsweek | by: Peter J. Pitts |
  • 09/17/2016
When 41-year-old New Jersey resident Amy Speicher was diagnosed with advanced skin cancer, she feared the disease as well as the hair loss, vomiting and crippling fatigue that usually come with cancer treatment.

None of that came to pass. Speicher sailed through her treatment, balancing parenting and a full-time job. How? Her insurance paid for a groundbreaking immunotherapy, which has far fewer side effects than run-of-the-mill chemo.
 
Unfortunately, her story is the exception. Throughout the country, insurers increasingly shun the most advanced cures, treatments and tests because they don't want to foot the bill. This short-term focus on profits is callous—and counterproductive. Denying patients the best health care leaves them sicker, ultimately raising insurers' expenses.

In recent years, insurers have replaced fixed co-pays—say, $20 at the pharmacy—with "co-insurance," where patients are asked to pay a percentage of an advanced medicines' total cost. Insurers know many patients can't afford these payments and will ask their doctors for less expensive—and often, less effective—medicines.

Insurers have also embraced "fail first" policies to limit patients' access to cutting-edge treatments. Such policies require patients to use cheaper treatments first. Only if those treatments fail—and patients get sicker—do insurers pony up for cutting-edge drugs.

Increasingly, insurers are also refusing to pay for some treatments unless a doctor first seeks permission before writing a prescription. Most drug regimens should begin immediately, so waiting days or even weeks for an insurer to approve a doctor's prescription simply isn't tenable.  
 
Sign Up for Our Email Newsletter

RECENT NEWS

ICER Perpetuates the Opioid Crisis

ICER Perpetuates the Opioid Crisis

The new ICER analysis enables cost-containment practices that will perpetuate this crisis....  Read more

Peter Pitts discusses Scott Gottlieb and Healthcare Reform on the Bill Martinez Radio Show

Peter Pitts discusses Scott Gottlieb and Healthcare Reform on the Bill Martinez Radio Show

CMPI President Peter Pitts discusses Senate confirmation process for Scott Gottlieb and the Healthcare Bill headed to the...  Read more

Blue Cross Blue Shield BS on Rx $

Blue Cross Blue Shield BS on Rx $

The policy shop of BCBS has released a report about drug costs that is deliberately deceptive and misleading. ...  Read more

DRUGWONKS BLOG